|
| | amyrin palmitate Basic information |
| Product Name: | amyrin palmitate | | Synonyms: | beta-amyrin palmitate;5α-Oleana-12-ene-3β-ol hexadecanoate;Hexadecanoic acid oleana-12-ene-3β-yl ester;Olean-12-en-3β-ol hexadecanoate;Oleana-12-ene-3β-ol palmitate;β-Amyrin 3-palmitate;Balanophorin A;Olean-12-en-3-ol,3-hexadecanoate, (3b)- | | CAS: | 5973-06-8 | | MF: | C46H80O2 | | MW: | 665.14 | | EINECS: | | | Product Categories: | | | Mol File: | 5973-06-8.mol |  |
| | amyrin palmitate Chemical Properties |
| Boiling point | 661.4±54.0 °C(Predicted) | | density | 0.97±0.1 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | LogP | 18.579 (est) |
| | amyrin palmitate Usage And Synthesis |
| Description | Beta-Amyrin palmitate may release norepinephrine from newly synthesized pools, and thus, it may activate noradrenergic activity.
Beta-Amyrin palmitate, like mianserin and imipramine, reduces the duration of immobility of mice significantly in a dose-dependent manner (5, 10 and 20 mg kg-1);
(1)Beta-Amyrin palmitate or mianserin elicits a dose-related reduction in locomotor activity of mice and antagonizes locomotor stimulation induced by methamphetamine, imipramine increases locomotor activity and potentiates methamphetamine-induced hyperactivity;
(2)Beta-Amyrin palmitate shows no effect on reserpine-induced hypothermia, whilst mianserin (10 mg kg-1) and imipramine (10 and 20 mg kg-1) antagonizes the reserpine-induced effect;
(3)Beta-amyrin palmitate has similar properties in some respects to mianserin and might possess a sedative action. | | target | LDL | HMG-CoA Reductase | Adrenergic Receptor |
| | amyrin palmitate Preparation Products And Raw materials |
|
